Angiotensin is a polypeptide in the blood that causes vasoconstriction, increased blood pressure, and aldosterone release from the adrenal cortex. It is derived from the precursor molecule angiotensinogen, a serum globulin produced in the liver. It plays an important role in the renin-angiotensin system.
Angiotensinogen consist of 453 amino acid residues.
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu
Angiotensin I (CAS# 11128-99-7) is formed by the action of renin on angiotensinogen. Renin is produced in the kidneys in response to both decreased intra-renal blood pressure at the JG cells, or decreased delivery of Na+ and Cl- to the macula densa. If more Na is sensed, renin release is decreased.
Renin cleaves the peptide bond between the leucine (Leu) and the valine (Val) residues on angiotensinogen, creating the ten amino acid peptide (des-Asp) angiotensin I (CAS# 9041-90-1).
Angiotensin I appears to have no biological activity and exists solely as a precursor to Angiotensin II.
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe | His-Leu
Angiotensin I is converted to Angiotensin II by removal of two terminal residues by the enzyme Angiotensin-converting enzyme (ACE, or kininase), which is found predominantly in pulmonary capillaries.
ACE is a target for inactivation by ACE inhibitor drugs, which decrease the rate of angiotensin II production. Other cleavage products, 7 or 9 amino acids long, are also known; they have differential affinity for angiotensin receptors, although their exact role is still unclear.
Angiotensin II is degraded to angiotensin III by angiotensinases that are located in red blood cells and the vascular beds of most tissues. It has a half-life in humans of 1-2 minutes.
Asp | Arg-Val-Tyr-Ile-His-Pro-Phe
Angiotensin III has 40% of the pressor activity of Angiotensin II, but 100% of the aldosterone-producing activity.
Arg | Val-Tyr-Ile-His-Pro-Phe
Angiotensin IV is a hexapeptide which, like angiotensin III, has some lesser activity.
Angiotensins II, III & IV have a number of effects throughout the body:
Angiotensin II has prothrombotic potential through adhesion and aggregation of platelets and production of PAI-1 and PAI-2.
It has been thought that angiotensin II could be a cause of vascular and cardiac muscle hypertrophy (when the heart wall grows bigger).
Angiotensin | Angiotensine | Angiotensine | アンギオテンシン | Angiotensyna | Angiotensina II | Angiotensin
This article is licensed under the GNU Free Documentation License.
It uses material from the
"Angiotensin".
Home Page • arts • business • computers • games • health • hospitals • home • kids & teens • news • physicians • recreation• reference • regional • science • shopping • society • sports • world